AMPE
Ampio Pharmaceuticals Inc.
AMPE
AMPE
Delisted
AMPE was delisted on the 12th of April, 2024.
81 hedge funds and large institutions have $7.96M invested in Ampio Pharmaceuticals Inc. in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
Holders
81
Holding in Top 10
1
Calls
$226K
Puts
$21K
Top Buyers
| 1 | +$2.04M | |
| 2 | +$736K | |
| 3 | +$205K | |
| 4 |
Goldman Sachs
New York
|
+$172K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$171K |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$398K | |
| 3 | -$314K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$142K |
| 5 |
MA
Montag & Associates
Atlanta,
Georgia
|
-$129K |